Internal Communications

Additional Information on Newly Published Research Policies

The newly published policies for Animal Use in Research, Teaching and Testing and Research Involving Human Subjects revise the existing UConn Storrs policies to establish a uniform regulatory compliance statement that applies to all campuses under which the programs at UConn Health and Storrs operate.  A single, overarching policy will help in the development of other policies and procedures to help facilitate cross-campus initiatives.

Key revisions:

  • Clarification of who the policies apply to (both policies)
  • Revisions to definitions to make them consistent with the regulatory definition (both policies)
  • Clarification regarding the role of the Institutional Official and committees (IACUC and IRB)
  • Clarification of the authority of the attending veterinarian to be consistent with regulatory requirements (Animal Use policy)
  • Clarification of the authority of the IRB to be consistent with regulatory requirements (Human Subjects Research policy)
  • Revisions to the enforcement section to make the sections consistent with other university policies (both policies)
  • Updated list of authorities (both policies)

 

The Human Stem Cell Research policy clarifies and updates the existing University-wide policy regarding the type and scope of research to which the policy applies.

 

The ClinicalTrials.gov policy establishes a new University-wide policy to address FDA, NIH and CMS requirements that applicable trials are registered.

 

Animal Use in Research, Teaching and Testing: https://policy.uconn.edu/?p=113

Human Stem Cell Research Approval: https://policy.uconn.edu/?p=2453

Human Subjects Research: https://policy.uconn.edu/?p=406

ClinicalTrials.gov: https://policy.uconn.edu/?p=7310

 

For additional information, contact Ellen Ciesielski (eciesielski@uchc.edu, 860-679-6004)

 

Revised & New University-Wide Research Policies

 

The Office of the Vice President for Research (OVPR) Research Compliance Services would like to share some important updates regarding university policies for animal use, human subjects, and stem cell research. These policies were revised to be consistent with federal requirements and are now in effect for all campuses, including UConn Health.  A new university-wide policy to address FDA, NIH, and CMS requirements for registration of applicable trials to ClinicalTrials.gov has also been published.

 

Please see links to published policies below.

 

ClinicalTrials.gov: https://policy.uconn.edu/?p=7310

Animal Use in Research, Teaching and Testing: https://policy.uconn.edu/?p=113

Human Stem Cell Research Approval: https://policy.uconn.edu/?p=2453

Human Subjects Research: https://policy.uconn.edu/?p=406

 

For additional information, contact Ellen Ciesielski (eciesielski@uchc.edu, 860-679-6004).

 

University Intellectual Property & Commercialization Policy Update

October 22, 2015

 

Dear Colleagues,

I am pleased to announce that an updated version of the University’s Intellectual Property and Commercialization Policy was approved by the Board of Trustees in early October and is now available online. This comes as the result of a substantive collaboration between the Office of the Vice President for Research, the Provost’s Office, the Office of the General Counsel and faculty and staff at both UConn-Storrs and UConn Health.

Although most of the substantive elements remain the same, the policy now provides a more comprehensive, consistent, and clear explanation of relevant issues, such as the use of University resources by a faculty-affiliated company, conflict of interest disclosures, and the hiring of students to work in faculty-affiliated companies, among others.

We are confident that this streamlined policy document, which applies to faculty, staff, and students at all UConn campuses, more accurately reflects the University’s belief that teaching, research, and economic development are enhanced by the intellectual property generated at UConn.

Should you have any questions related to the updated Intellectual Property and Commercialization Policy, please contact:

 

Gregory Gallo, PhD
Director
Technology Commercialization Services
Office of the Vice President for Research
Tel. 860-679-3992
gregory.gallo@uconn.edu

 

Sincerely,

Dr. Jeff Seemann
Vice President for Research
UConn/UConn Health